Job Description
As a (Senior) Director of Preclinical Programs, you will lead a team of scientists to design and engineer immune-modulating biologics, and advance candidate molecules from hit-to-lead by integrating traditional preclinical pharmacology approaches with Immunai’s platform-enabled workflows for preclinical asset evaluation. You will identify, prioritize and optimize promising lead molecules for potential partnering or investment for internal development.
Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.
